Kemnay Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
TGA
RCMNY
Kemnay Advisory Services's AMRX Position: Q2 2026 in Review
Kemnay Advisory Services increased its Amneal Pharmaceuticals (AMRX) stake by 17% in Q2 2026, buying an estimated $3.18K and bringing the position to 1,620 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #538.
Kemnay Advisory Services first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Kemnay Advisory Services held 1,620 shares of Amneal Pharmaceuticals worth $28K as of Q2 2026.
- Kemnay Advisory Services bought 232 Amneal Pharmaceuticals shares in Q2 2026, an estimated $3.18K.
- Amneal Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #538 holding.
- Kemnay Advisory Services first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.